Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - September 2014


Biomarker Utilisation & Commercialisation

10 Sep 2014 - 11 Sep 2014 - London, UK



Bookmark and Share


The ACI Biomarker Utilisation & Commercialisation conference will take place on the 10th & 11th September in London. The event will explore the value of biomarkers from both a clinical and commercial perspective.

The aim of the event is to help end-users to develop a comprehensive strategy for biomarker discovery, development, application and analysis in clinical trials.
Attendees will get to meet renowned experts in biomarkers to discuss and debate key issues. All this takes place in a friendly environment designed to encourage networking between participants.

Topics on the agenda:
Benefit from an instructive two-day programme that explores a range of clinical and commercial factors affecting decision-makers in the world of biomarkers, combined with the opportunity for interaction with key opinion leaders.

Presentation Topics Include:
* Creating and Capturing Value with Biomarkers.
* Innovative Commercialisation of Companion Diagnostic Solutions 
* The Use of Human Genetics to Identify Novel Biomarkers for Clinical Trials
* Biomarker Discovery to Diagnostic Development: What are the Challenges? 
* Applying Imaging Biomarkers to Reduce Risk in Drug Development 
* Intellectual Property Protection for Biomarker Utilisation 
* Biomarkers in Personalised Medicine: From Discovery to Repositioning 
* Statistical Innovations in Biomarker Utilisation

Confirmed speaker companies include:
* Teva * Pfizer * Bayer Schering Pharma * Roche Diagnostics * Actelion * Comprehensive Biomarker Center GmbH * TNO * Biogerontology Research Foundation * Eisai * Westminster Genomic Services * Harrison Goddard Foote LLP * Cambridge Consultants * University College Dublin * Lloyd’s Register Quality Assurance (LRQA) * Medimmune * University College Dublin * Imanova *

For a copy of the conference programme or to register your attendance contact Cheryl Williams on +44 (0) 203 141 0623 or email cwilliams@acieu.net


Further information
Scientific News
Tracking Breast Cancer Before it Grows
A team of scientists led by University of Saskatchewan researcher Saroj Kumar is using cutting-edge Canadian Light Source techniques to screen and treat breast cancer at its earliest changes.
The Light of Fireflies for Medical Diagnostics
EPFL scientists have exploited the light of fireflies in a new method that detects biological molecules without the need for complex devices and high costs.
Could a simple saliva test detect Alzheimer's?
Researchers have presented findings suggesting that a simple, non-invasive diagnostic for Alzheimer's could be within reach.
Cheap Diagnostics with a Portable "Paper Machine"
Scientists have developed a cheap, portable system for point of care diagnostics for a range of infectious diseases, genetic conditions and cancer.
New Variant of Streptococcal Bacteria
Scientists have discovered a new variant of streptococcal bacteria that has contributed to a rise in disease cases in the UK over the last 17 years.
New Insights into “Antenna” of Human Cells
Scientists from the University of Leeds have uncovered the most comprehensive list yet of genes implicated in a group of common inherited diseases.
Discordant NIPT Test Results May Reflect Presence of Maternal Cancer
Results published in Journal of the American Medical Association.
Sperm RNA Test May Improve Evaluation of Male Infertility
To help resolve uncertainty—and guide prospective parents to the right fertility treatments—scientists propose the use of a new kind of fertility test. It involves examining sperm RNA by means of next-generation sequencing.
Optical 'Dog's Nose' Developed to Detect Cancer, Other Diseases
Researchers are using optical spectroscopy to develop a quick, non-invasive “breath test” they believe will have the potential to screen for a variety of diseases, including diabetes, infections and cancers.
Ebola Assays Compared in Head-to-Head Analysis
A newly published study has attempted to rigorously evaluate a few of the assays recently granted Emergency Use Authorization by the US Food and Drug Administration to test for Ebola Zaire virus.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!